Paradoxical adverse events of anti-tumour necrosis factor therapy for spondyloarthropathies: a retrospective study. (Q47938362)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19395543%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

title

Paradoxical adverse events of anti-tumour necrosis factor therapy for spondyloarthropathies: a retrospective study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19395543%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19395543%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

author name string

Damien Fouache

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19395543%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Nathalie Massy-Guillemant

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19395543%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Gilles Avenel

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19395543%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Helene Bacquet-Deschryver

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19395543%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Macha Kozyreff-Meurice

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19395543%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Jean-François Ménard

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19395543%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Marc Muraine

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19395543%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Guillaume Savoye

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19395543%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Xavier Le Loët

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19395543%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Christine Tharasse

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19395543%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Olivier Vittecoq

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19395543%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

publication date

24 April 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19395543%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19395543%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

volume

48

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19395543%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19395543%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

page(s)

761-764

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19395543%20AND%20SRC:MED&resulttype=core&format=json

Prevalence of spondyloarthropathies in France: 2001.

26 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEP083

Biological therapies in the spondyloarthritides--the current state

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEP083

ASAS/EULAR recommendations for the management of ankylosing spondylitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEP083

Differences in the incidence of flares or new onset of inflammatory bowel diseases in patients with ankylosing spondylitis exposed to therapy with anti-tumor necrosis factor alpha agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEP083

Anti-tumor necrosis factor-alpha therapy with infliximab as an alternative to corticosteroids in the treatment of human leukocyte antigen B27-associated acute anterior uveitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEP083

Decreased incidence of anterior uveitis in patients with ankylosing spondylitis treated with the anti-tumor necrosis factor agents infliximab and etanercept

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEP083

Focus on adverse events of tumour necrosis factor alpha blockade in juvenile idiopathic arthritis in an open monocentric long-term prospective study of 163 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEP083

TNF-alpha blockade down-regulates the CD40/CD40L pathway in the mucosal microcirculation: a novel anti-inflammatory mechanism of infliximab in Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEP083

Increased peripheral T cell reactivity to microbial antigens and collagen type II in rheumatoid arthritis after treatment with soluble TNFalpha receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEP083

Up regulation of the production of tumour necrosis factor alpha and interferon gamma by T cells in ankylosing spondylitis during treatment with etanercept

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEP083